Vanguard Group Inc Elanco Animal Health Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Vanguard Group Inc holds 48,945,483 shares of ELAN stock, worth $654 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
48,945,483
Previous 49,447,813
1.02%
Holding current value
$654 Million
Previous $714 Million
0.7%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1.11 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$702 Million0.58% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$311 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$285 Million11.09% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD21MShares$281 Million0.19% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.33B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...